Involved Field Radiotherapy

RADIATION2 trials

Sponsors

Trans Tasman Radiation Oncology Group, University College, London

Conditions

LymphomaNon-gastric Marginal Zone Lymphoma

Phase 2

Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma

Trans Tasman Radiation Oncology GroupNon-gastric Marginal Zone Lymphoma

Start: 2007-07-08End: 2019-04-30Updated: 2018-02-28

Phase 3

PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

Active, not recruitingNCT00943423

University College, LondonLymphoma

Start: 2003-07-31End: 2028-12-31Updated: 2023-11-30

Related Papers

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study

Blood Advances2025-01-073 citations

Enhanced Outcome Prediction in Early Stage Classical Hodgkin Lymphoma Using Pre-Treatment Biomarkers and Interim PET (BioPET); A Sub-Analysis of the UK NCRI RAPID Trial

Blood2020-11-042 citations

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

New England Journal of Medicine2015-04-22734 citations